Assessment of molecular imaging of angiogenesis with three-dimensional ultrasonography

Molecular Imaging

Volumn 10, Issue 6, 2011, Pages 460-468

  Streeter, Jason E ^a   Gessner, Ryan C ^a   Tsuruta, James ^a   Feingold, Steven ^a   Dayton, Paul A ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; ASSESSMENT TECHNIQUE; FIELD OF VIEWS; HETEROGENEOUS TISSUES; IMMUNOHISTOCHEMICAL ANALYSIS; INTEGRINS; MICRO-BUBBLE; MICROBUBBLE CONTRAST AGENTS; MOLECULAR IMAGING; PHENOTYPIC CHANGES; RGD PEPTIDE; SERIAL STUDIES; SIEMENS; SUBSTANTIAL ERRORS; THREE-DIMENSIONAL (3D); THREE-DIMENSIONAL ULTRASONOGRAPHY; TUMOR ANGIOGENESIS; VOLUMETRIC ACQUISITIONS;

THREE DIMENSIONAL; ULTRASONIC APPLICATIONS; ULTRASONOGRAPHY; VISUALIZATION; VOLUMETRIC ANALYSIS;

TUMORS;

ARGINYL-GLYCYL-ASPARTIC ACID; ARGINYLGLYCYLASPARTIC ACID; CONTRAST MEDIUM; DIAGNOSTIC AGENT; OLIGOPEPTIDE; VITRONECTIN RECEPTOR;

ANIMAL; ARTICLE; BIOSYNTHESIS; CHEMISTRY; ECHOGRAPHY; EXPERIMENTAL NEOPLASM; FIBROSARCOMA; IMMUNOHISTOCHEMISTRY; METHODOLOGY; MICROBUBBLE; MOLECULAR IMAGING; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; RAT; THREE DIMENSIONAL IMAGING; VASCULARIZATION;

ANIMALS; CONTRAST MEDIA; FIBROSARCOMA; IMAGING, THREE-DIMENSIONAL; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHAVBETA3; MICROBUBBLES; MOLECULAR IMAGING; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; OLIGOPEPTIDES; RATS; ULTRASONOGRAPHY;

EID: 84855300532     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2011.00015     Document Type: Article

References (38)

1. Lindner JR. Molecular imaging of cardiovascular disease with contrast-enhanced ultrasonography. Nat Rev Cardiol 2009;6:475-81.
2. Leong-Poi H, Christiansen J, Klibanov AL, et al. Noninvasive assessment of angiogenesis by ultrasound and microbubbles targeted to alpha (v)-integrins. Circulation 2003;107:455-60, doi:10.1161/01. CIR.0000044916.05919.8B. (Pubitemid 36158049)
3. Dayton PA, Ferrara KW. Targeted imaging using ultrasound. J Magn Reson Imaging 2002;16:362-77, doi:10.1002/jmri.10173. (Pubitemid 35167872)
4. Gessner R, Dayton PA. Advances in molecular imaging with ultrasound. Mol Imaging 2010;9:117-27.
5. Dayton PA, Pearson D, Clark J, et al. Ultrasonic analysis of peptide-and antibody-targeted microbubble contrast agents for molecular imaging of alphavbeta3-expressing cells. Mol Imaging 2004;3:125-34, doi:10.1162/ 1535350041464883.
6. Dayton PA, Rychak JJ. Molecular ultrasound imaging using microbubble contrast agents. Front Biosci 2007;12:5124-42, doi:10.2741/2553.
7. Lanza G, Wickline S. Targeted ultrasonic contrast agents for molecular imaging and therapy. Curr Probl Cardiol 2003;28:625-53, doi:10.1016/j.cpcardiol. 2003.11.001.
8. Willmann JK, Paulmurugan R, Chen K, et al. US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. Radiology 2008;246:508-18, doi:10.1148/radiol. 2462070536.
9. Schumann PA, Christiansen JP, Quigley RM, et al. Targetedmicrobubble binding selectively to GPIIb IIIa receptors of platelet thrombi. Invest Radiol 2002;37:587-93, doi:10.1097/00004424-200211000-00001. (Pubitemid 35231692)
10. Villanueva FS, Lu E, Bowry S, et al. Myocardial ischemic memory imaging with molecular echocardiography. Circulation 2007;115:345-52, doi:10.1161/CIRCULATIONAHA.106.633917. (Pubitemid 46151660)
11. Lanza G, Wallace K, Scott M, et al. A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation 1996;94:3334-40. (Pubitemid 26427506)
12. Ferrara KW, Borden MA, Zhang H. Lipid-shelled vehicles: engineering for ultrasound molecular imaging and drug delivery. Acc Chem Res 2009;42:881-92, doi:10.1021/ar8002442.
13. Suzuki R, Oda Y, Utoguchi N, et al. A novel strategy utilizing ultrasound for antigen delivery in dendritic cell-based cancer immunotherapy. J Control Release 2009;133:198-205, doi:10.1016/j.jconrel.2008.10.015.
14. Stieger SM, Dayton PA, Borden MA, et al. Imaging of angiogenesis using cadence contrast pulse sequencing and targeted contrast agents. Contrast Media Mol Imaging 2008;3:9-18, doi:10.1002/cmmi.224. (Pubitemid 351493974)
15. Kuliszewski MA, Fujii H, Liao C, et al. Molecular imaging of endothelial progenitor cell engraftment using contrast-enhanced ultrasound and targeted microbubbles. Cardiovasc Res 2009;83:653-62, doi:10.1093/cvr/cvp218.
16. Kaufmann BA, Wei K, Lindner JR. Contrast echocardiography. Curr Probl Cardiol 2007;32:51-96, doi:10.1016/j.cpcardiol.2006.10.004. (Pubitemid 46037828)
17. Dayton PA, Morgan KE, Klibanov AL, et al. Optical and acoustical observations of the effects of ultrasound on contrast agents. IEEE Trans Ultrason Ferroelectr Freq Control 1999;46:220-32, doi:10.1109/58.741536.
18. Streeter JE, Gessner R, Miles I, et al. Improving sensitivity in ultrasound molecular imaging by tailoring contrast agent size distribution: in vivo studies. Mol Imaging 2010;9:87-95.
19. Pollard RE, Dayton PA, Watson KD, et al. Motion corrected cadence CPS ultrasound for quantifying response to vasoactive drugs in a rat kidney model. Urology 2009;74:675-81, doi:10.1016/j.urology.2009.01.086.
20. Feingold S, Gessner RC, Guracar IM, et al. Quantitative volumetric perfusion mapping of the microvasculature using contrast ultrasound. Invest Radiol 2010;45:669-74.
21. Hickson J. In vivo optical imaging: preclinical applications and considerations. URO 2010;27:295-7.
22. Bengel FM. Clinical cardiovascular molecular imaging. J Nucl Med 2009;50:837-40, doi:10.2967/jnumed.108.059246.
23. Rankin RN, Fenster A, Downey DB, et al. Three-dimensional sonographic reconstruction: techniques and diagnostic applications. AJR Am J Roentgenol 1993;161:695-702. (Pubitemid 23296614)
24. Mor-Avi V, Sugeng L, Lang RM. Three-dimensional adult echocardiography: where the hidden dimension helps. Curr Cardiol Rep 2008;10:218-25, doi:10.1007/s11886-008-0037-x.
25. Coyne L, Jayaprakasan K, Raine-Fenning N. 3D ultrasound in gynecology and reproductive medicine. Womens Health (London, Engl) 2008;4:501-16.
26. Leen E, Kumar S, Khan SA, et al. Contrast-enhanced 3D ultrasound in the radiofrequency ablation of liver tumors. World J Gastroenterol 2009;15:289-99, doi:10.3748/wjg.15.289.
27. Luo W, Numata K, Morimoto M, et al. Three-dimensional contrast-enhanced sonography of vascular patterns of focal liver tumors: pilot study of visualization methods. AJR Am J Roentgenol 2009;192:165-73, doi:10.2214/AJR.08. 1107.
28. Reinhardt M, Hauff P, Linker RA, et al. Ultrasound derived imaging and quantification of cell adhesion molecules in experimental autoimmune encephalomyelitis (EAE) by Sensitive Particle Acoustic Quantification (SPAQ). Neuroimage 2005;27:267-78, doi:10.1016/j.neuroimage.2005.04.019. (Pubitemid 41074830)
29. Reinhardt M, Hauff P, Briel A, et al. Sensitive particle acoustic quantification (SPAQ): a new ultrasound-based approach for the quantification of ultrasound contrast media in high concentrations. Invest Radiol 2005;40:2-7. (Pubitemid 40029887)
30. Kaya M, Feingold S, Streeter JE, et al. Acoustic responses of monodisperse lipid-encapsulated microbubble contrast agents produced by flow focussing. IEEE Ultrasonics Symposium Proceedings; 2009 September; Rome, Italy.
31. Sirsi S, Feshitan J, Kwan J, et al. Effect of microbubble size on fundamental mode high frequency ultrasound imaging in mice. Ultrasound Med Biol 2010;36:935-48, doi:10.1016/j.ultrasmedbio. 2010.03.015.
32. Feshitan JA, Chen CC, Kwan JJ, et al. Microbubble size isolation by differential centrifugation. J Colloid Interface Sci 2009;329:316-24, doi:10.1016/j.jcis.2008.09.066.
33. Jung K-H, Lee K-H, Paik J-Y, et al. Favorable biokinetic and tumor-targeting properties of 99mTc-labeled glucosamino RGD and effect of paclitaxel therapy. J Nucl Med 2006;47:2000-7. (Pubitemid 47544988)
34. Lindner JR, Song J, Xu F, et al. Noninvasive ultrasound imaging of inflammation using microbubbles targeted to activated leukocytes. Circulation 2000;102:2745-50.
35. Willmann JK, Lutz AM, Paulmurugan R, et al. Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo. Radiology 2008;248:936-44, doi:10.1148/radiol.2483072231.
36. Weller GER, Wong MKK, Modzelewski RA, et al. Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine. Cancer Res 2005;65:533-9.
37. Weinberg RA. The biology of cancer. New York: Garland Science Taylor & Francis Group; 2007.
38. Pichler BJ, Kneilling M, Haubner R, et al. Imaging of delayed-type hypersensitivity reaction by PET and 18F-galacto-RGD. J Nucl Med 2005;46:184-9. (Pubitemid 43086015)